#VisualAbstract: Every-other-day dosing of oral rimegepant is effective for preventive treatment of migraines

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Neurological conditions, Neurology

#VisualAbstract: Every-other-day dosing of oral rimegepant is effective for preventive treatment of migraines

2 Minute Medicine

Jan 19, 2021

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Oncology, Haematological malignancies, Oncology Room

#VisualAbstract AMLSG 09-09: Adding getuzumab ozogamicin (GO) to intensive therapy for Nucleophosmin1 mutated acute myeloid leukemia (NPM1mut AML) leads to better NPM1mut transcript clearance and a lower replase rate

2 Minute Medicine

Jan 15, 2021

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Cancer, Oncology, Skin cancer, Oncology Room

#VisualAbstract: Durvalumab, trametinib, and dabrafenib triplet therapy may provide robust immunogenicity in patients with BRAF-mutated advanced melanoma

2 Minute Medicine

Jan 15, 2021

#VisualAbstract: SWOG-1211: Addition of elotuzumab to RVd induction and maintenance (lenalidomide, bortezomib, dexamethasone) did not improve patient outcomes in untreated, high-risk multiple myeloma

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Haematological malignancies

#VisualAbstract: SWOG-1211: Addition of elotuzumab to RVd induction and maintenance (lenalidomide, bortezomib, dexamethasone) did not improve patient outcomes in untreated, high-risk multiple myeloma

2 Minute Medicine

Jan 15, 2021

#VisualAbstract: Carboplatin as a potential adjunct therapy for recurrent high-grade glioma treatment

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Neurology, Oncology Room

#VisualAbstract: Carboplatin as a potential adjunct therapy for recurrent high-grade glioma treatment

2 Minute Medicine

Jan 14, 2021

#VisualAbstract: Everolimus plus leuprorelin and letrozole improves progression-free survival in HR⁺, HER2⁻ metastatic breast cancer patients with visceral metastases

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Oncology, Breast cancer, Oncology Room

#VisualAbstract: Everolimus plus leuprorelin and letrozole improves progression-free survival in HR⁺, HER2⁻ metastatic breast cancer patients with visceral metastases

2 Minute Medicine

Jan 13, 2021

#VisualAbstract: Outcomes associated with discontinuation of RASi in patients with chronic kidney disease

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Kidney conditions

#VisualAbstract: Outcomes associated with discontinuation of RASi in patients with chronic kidney disease

2 Minute Medicine

Jan 13, 2021

#VisualAbstract: Occult blood in faeces is associated with an increased risk of ischemic stroke and myocardial infarction

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Neurology

#VisualAbstract: Occult blood in faeces is associated with an increased risk of ischemic stroke and myocardial infarction

2 Minute Medicine

Jan 12, 2021

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Oncology, Haematological malignancies, Oncology Room

#VisualAbstract: Fondazione Italiana Linfomi (FIL) Phase 3 trial: Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation (HSCT) in mantle cell lymphoma improves progression-free survival (PFS)

2 Minute Medicine

Jan 08, 2021

#VisualAbstract: Progression-Free Survival (PFS) was significantly longer with intensive chemotherapy in patients with advanced stage double or triple hit lymphoma (DHL, THL)

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Cancer, Oncology, Haematological malignancies

#VisualAbstract: Progression-Free Survival (PFS) was significantly longer with intensive chemotherapy in patients with advanced stage double or triple hit lymphoma (DHL, THL)

2 Minute Medicine

Jan 08, 2021

#VisualAbstract: Low-dose capecitabine after standard adjuvant therapy improves disease-free survival in patients with early triple-negative breast cancer

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Cancer, Breast cancer, Oncology Room

#VisualAbstract: Low-dose capecitabine after standard adjuvant therapy improves disease-free survival in patients with early triple-negative breast cancer

2 Minute Medicine

Jan 08, 2021

#VisualAbstract: Use of inhaled corticosteroids is not associated with improved COVID-related mortality in patients with chronic respiratory conditions

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Respiratory conditions, Respiratory, COVID-19 Room

#VisualAbstract: Use of inhaled corticosteroids is not associated with improved COVID-related mortality in patients with chronic respiratory conditions

2 Minute Medicine

Jan 07, 2021

#VisualAbstract: Total body skin examinations may aid in the detection of incidental skin cancers in patients with suspicious lesions

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Cancer, Skin conditions, Dermatology, Skin cancer

#VisualAbstract: Total body skin examinations may aid in the detection of incidental skin cancers in patients with suspicious lesions

2 Minute Medicine

Jan 07, 2021

#VisualAbstract: Cabotegravir plus rilpivirine given every 8 weeks is non-inferior to every 4 weeks for maintenance of HIV-1 viral suppression

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings

#VisualAbstract: Cabotegravir plus rilpivirine given every 8 weeks is non-inferior to every 4 weeks for maintenance of HIV-1 viral suppression

2 Minute Medicine

Jan 07, 2021

#VisualAbstract: DIVERSITY trial: Dabigatran etexilate was non-inferior to standard of care in effectively treating acute venous thromboembolism (VTE) in children

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings

#VisualAbstract: DIVERSITY trial: Dabigatran etexilate was non-inferior to standard of care in effectively treating acute venous thromboembolism (VTE) in children

2 Minute Medicine

Jan 04, 2021

#VisualAbstract: Presence of regression is a favourable prognostic factor for patients with stage I and II cutaneous melanoma

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Cancer, Skin cancer, Oncology Room

#VisualAbstract: Presence of regression is a favourable prognostic factor for patients with stage I and II cutaneous melanoma

2 Minute Medicine

Jan 04, 2021

#VisualAbstract: Administering bortezomib on a weekly basis VS twice weekly basis does not significantly affect progression-free survival (PFS) or overall survival (OS) in Vrd first-line therapy for multiple myeloma

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Haematological malignancies, Oncology Room

#VisualAbstract: Administering bortezomib on a weekly basis VS twice weekly basis does not significantly affect progression-free survival (PFS) or overall survival (OS) in Vrd first-line therapy for multiple myeloma

2 Minute Medicine

Jan 01, 2021

#VisualAbstract: Low mammographic breast density may be associated with an increased risk of developing severe lymphedema

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Oncology, Breast cancer, Oncology Room

#VisualAbstract: Low mammographic breast density may be associated with an increased risk of developing severe lymphedema

2 Minute Medicine

Dec 31, 2020

#VisualAbstract: Special Report: Johnson & Johnson one of top 5 COVID-19 vaccine finalists

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, COVID-19 Room

#VisualAbstract: Special Report: Johnson & Johnson one of top 5 COVID-19 vaccine finalists

2 Minute Medicine

Dec 24, 2020

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Oncology, Skin cancer, Oncology Room

#VisualAbstract: Low plasma ctDNA may be predictive of better survival outcomes in patients with melanoma receiving first-line immune checkpoint inhibitors

2 Minute Medicine

Dec 24, 2020